Bottom Line:
💡 BUY OPPORTUNITY: EFX shows positive signals but monitor for confirmation. Market pricing in 8.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)50% (Hyper Growth)
EST. PRICE IN 2031
$392.74
Based on 11.9% avg growth
INTRINSIC VALUE TODAY
$243.86
27.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.8x Exit PE.
Valuation Analysis: EFX is currently trading at $177.20, which is considered oversold relative to its 30-day fair value range of $179.35 to $203.69. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.6) compared to its historical average (21.8). Remarkably, the market is currently pricing in an annual earnings decline of 8.7% over the next few years. This pessimistic expectation contrasts with the company's recent 2.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, EFX is in a downtrend. Immediate support is located at $166.07, while resistance sits at $192.11. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: EFX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $237.35 (+38.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$179.35 -
$203.69
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Strong upward momentum (+3.1%)
BULLISH: Trading 38.1% below Wall St target ($237.35)
Fair Price Analysis
30-Day Fair Range
$179.35 -
$203.69
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level$166.07
Resistance Level$192.11
Current TrendDowntrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)16.60
Wall Street Target
$237.35
(+38.1%)
Revenue Growth (YoY)9.2%
Earnings Growth (YoY)2.4%
Profit Margin10.9%
Valuation Discount vs History
-8.7% cheaper
PE vs Historical
16.6 vs 21.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):-8.7%
(market-implied from PE analysis)
1-Year Target
$156.90
(-9%)
2-Year Target
$143.25
(-17%)
3-Year Target
$130.79
(-24%)
3-Yr Target (if PE normalizes)
(PE: 17→22)
$171.80
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, over 40% of the firm's revenue comes from workforce solutions, which provides income verification and employer human resources services. Equifax generates about 20%-25% of its revenue from outside the United States.